Group 6

2 trials

Sponsors

Centre for the AIDS Programme of Research in South Africa, Kilimanjaro Clinical Research Institute

Conditions

COVID-19HIV/AIDS

Phase 1

Active, not recruitingPACTR201808919297244

Centre for the AIDS Programme of Research in South AfricaHIV/AIDS

Start: 2018-10-01Target: 45Updated: 2026-08-03

Active, not recruitingPACTR202107612488277

Kilimanjaro Clinical Research InstituteCOVID-19

Start: 2022-03-01Target: 169Updated: 2026-08-03

Related Papers

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial

BMJ Open2019-07-0116 citations